Indaptus Therapeutics, Inc.INDPNASDAQ
Loading
Gross Profit Growth Under PressureDecelerating
Percentile Rank16
Year-over-Year Change
Year-over-year gross profit growth rate
Latest
0.00%
↓ 100% vs avg
Percentile
P16
Within normal range
Average
1.69%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | 0.00% |
| Q2 2025 | 0.00% |
| Q1 2025 | 0.00% |
| Q4 2024 | 0.00% |
| Q3 2024 | 0.00% |
| Q2 2024 | 0.00% |
| Q1 2024 | 0.00% |
| Q4 2023 | 0.00% |
| Q3 2023 | 0.00% |
| Q2 2023 | 0.00% |
| Q1 2023 | 0.00% |
| Q4 2022 | 0.00% |
| Q3 2022 | 0.00% |
| Q2 2022 | 0.00% |
| Q1 2022 | 0.00% |
| Q4 2021 | 0.00% |
| Q3 2021 | 0.00% |
| Q2 2021 | 0.00% |
| Q1 2021 | 0.00% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 100.00% |
| Q4 2019 | 0.47% |
| Q3 2019 | 0.47% |
| Q2 2019 | 2.29% |
| Q1 2019 | 0.91% |
| Q4 2018 | 1.35% |
| Q3 2018 | -6.19% |
| Q2 2018 | -1.94% |
| Q1 2018 | 4.63% |
| Q4 2017 | -1.41% |
| Q3 2017 | 0.00% |
| Q2 2017 | 100.00% |
| Q1 2017 | 0.00% |
| Q4 2015 | -105.01% |
| Q3 2015 | -28.09% |
| Q2 2015 | -1.53% |
| Q1 2015 | 0.00% |